Mitaka et al., 2011 - Google Patents
Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shockMitaka et al., 2011
View PDF- Document ID
- 942322874472685751
- Author
- Mitaka C
- Tomita M
- Publication year
- Publication venue
- Shock
External Links
Snippet
Endotoxin, an outer membrane component of gram-negative bacteria, plays an important role in the pathogenesis of septic shock. Endotoxin adsorption therapy by polymyxin B- immobilized fiber column hemoperfusion (PMX) has been used for the treatment of septic …
- 206010040070 Septic shock 0 title abstract description 47
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation; Extra-corporeal blood circuits
- A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation; Extra-corporeal blood circuits by absorption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mitaka et al. | Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock | |
Vincent et al. | A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection | |
Moriyama et al. | Targeting cytokines, pathogen-associated molecular patterns, and damage-associated molecular patterns in sepsis via blood purification | |
Esteban et al. | Immunomodulation in sepsis: The role of endotoxin removal by polymyxin B‐immobilized cartridge | |
Ekdahl et al. | Cardiovascular disease in haemodialysis: role of the intravascular innate immune system | |
Davies et al. | Endotoxin removal devices for the treatment of sepsis and septic shock | |
Shoji | Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin) | |
Madore | Plasmapheresis: technical aspects and indications | |
Zhou et al. | Blood purification and mortality in sepsis: a meta-analysis of randomized trials | |
Rimmelé et al. | High-volume haemofiltration with a new haemofiltration membrane having enhanced adsorption properties in septic pigs | |
Tetta et al. | Coupled plasma filtration-adsorption in a rabbit model of endotoxic shock | |
Reinhart et al. | Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected Gram-negative sepsis | |
Rimmelé et al. | Leukocyte capture and modulation of cell-mediated immunity during human sepsis: an ex vivo study | |
Sun et al. | High-volume hemofiltration plus hemoperfusion for hyperlipidemic severe acute pancreatitis: a controlled pilot study | |
Losappio et al. | Molecular mechanisms of premature aging in hemodialysis: the complex interplay between innate and adaptive immune dysfunction | |
Kozek-Langenecker et al. | Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration | |
Yamashita et al. | Clinical effects of a longer duration of polymyxin B‐immobilized fiber column direct hemoperfusion therapy for severe sepsis and septic shock | |
Mitaka et al. | A longer duration of polymyxin B-immobilized fiber column hemoperfusion improves pulmonary oxygenation in patients with septic shock | |
Chu et al. | Clinical effects of hemoperfusion combined with pulse high-volume hemofiltration on septic shock | |
Tani et al. | Anti-endotoxin properties of polymyxin B-immobilized fibers | |
Perl et al. | Therapeutic accessibility of caspase-mediated cell death as a key pathomechanism in indirect acute lung injury | |
Tani et al. | Extracorporeal removal of endotoxin: the polymyxin B-immobilized fiber cartridge | |
Coppo et al. | Infectious diseases as a trigger in thrombotic microangiopathies in intensive care unit (ICU) patients? | |
Mehta et al. | Extracorporeal blood purification strategies in sepsis and septic shock: An insight into recent advancements | |
Zhou et al. | Application of oXiris-continuous hemofiltration adsorption in patients with sepsis and septic shock: a single-centre experience in China |